Dernières nouvelles pour Cogent Biosciences (NASDAQ:COGT) Stock

COGENT BIOSCIENCES INC

Cogent Biosciences

Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Cogent Biosciences Inc

Costco Wholesale Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COST#NASDAQ">COST</a>) shares are trending on Thursday with shares up more than 1.5%. Here&#8217;s a look at <a href="https://www.benzinga.com/news/earnings/25/05/45436534/walmart-doesnt-alter-annual-outlook-yet-ceo-says-all-tariffs-create-cost-pressures-but-china-has-biggest-impact">what&#8217;s going on</a>.
What To Know: Costco shares are moving higher Thursday, adding to gains of nearly 10% since the start of the year. The stock has almost recovered all of its losses since its last earning report in early March, which included a <a href="https://www.benzinga.com/news/earnings/25/03/44180426/costco-q2-earnings-revenue-beat-eps-miss-comps-up-6-8-driven-by-strength-in-the-us">shortfall on earnings</a>. Management also provided cautious commentary on the earnings call in anticipation of tariffs.
The stock appears to be getting a boost from Walmart Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) earnings on Thursday. Walmart shares initially traded higher on the report, and Costco shares followed. Walmart shares have since pulled back, but Costco shares are holding onto gains. 
On the conference call, Walmart executives noted that February was soft, but demand returned to normal in March and was stronger than expected in April. Walmart also reaffirmed its guidance for full-year 2025, which may be fueling some optimism for Costco&#8217;s upcoming report.
Costco is due to report fiscal third-quarter results in the coming weeks. The company is expected to report earnings of $4.24 per share and revenue of $63.21 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a> estimates. 
Costco said last week that net sales in April were up 7% on a year-over-year basis. Net sales since the start of the year were up 8.2%, the membership-based wholesale retailer said. 
JPMorgan reiterated an Overweight rating on Costco last week, highlighting <a href="https://www.benzinga.com/analyst-ratings/price-target/25/05/45298451/jpmorgan-sees-more-upside-for-costco-as-us-sales-e-commerce-outperform">strong global momentum</a> and a rebound in big-ticket items, which account for about 20% of the retailer&#8217;s core sales.
It&#8217;s worth noting that Costco also showed up on Benzinga&#8217;s <a href="https://www.benzinga.com/trading-ideas/25/05/45335286/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-64">&#8220;Stock Whisper&#8221; index</a> last week, suggesting investors are optimistic about the stock with earnings on the horizon. 
Costco on Wednesday announced a multi-year partnership <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45414504/affirm-brings-buy-now-pay-later-to-costco-shoppers">with Affirm</a>, adding pay-over-time options for Costco.com in the U.S. Costco&#8217;s e-commerce sales climbed 12.6% year-over-year in April. 
COST Price Action: <a href="http://benzinga.com/quote/cost">Costco shares</a> were up 1.50% at $1,006.46 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45435725/tariffs-slow-retail-spending-as-producer-prices-post-sharpest-drop-since-2020">Tariffs Slow Retail Spending As Producer Prices Post Sharpest Drop Since 2020</a></li>
</ul>
Photo: teve Travelguide/Shutterstock.

Earnings

News

Previews

Movers

COST

Costco Stock Is Trending Thursday: What's Going On?

A Reddit user recently shared a frustrating discovery in a <a href="https://www.reddit.com/r/mildlyinfuriating/comments/1kiuz4m/my_mom_says_we_dont_have_enough_money_but_i_catch/">post</a> titled, &#8220;My mom says we don't have enough money, but I catch her giving thousands of dollars monthly to a megachurch.&#8221;&nbsp;
The post included a screenshot of a recent $600 donation receipt to Bill Winston Ministries. It showed $300 for tithes, $100 for missions, and $30 for the &#8216;Airplane Fund.&#8217;
Don't Miss:
<ul class="wp-block-list">
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
<li>The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?</li>
</ul>
<h2 class="wp-block-heading">Financial Strain and Surprising Expenses</h2>
The post blew up with responses, with many calling out how <a href="https://www.benzinga.com/personal-finance/25/04/44587016/dave-ramsey-says-a-600k-salary-should-be-enough-so-why-is-this-couple-living-paycheck-to-paychec">wild some of the expenses</a> were. One user pointed out the irony of the airplane fund, saying, &#8220;Airplane Fund is literally paying for the owner&#8217;s private jet lol.&#8221; Another added, &#8220;And ‘tributes to BWM' is a typo: they meant BMW.&#8221;
Some jumped in to share their own stories about parents who put church donations ahead of basic needs. One wrote, &#8220;I grew up in one of these churches. My mom was tithing 20 percent during the ‘08 financial crisis. We were on a Spaghetti-O diet because of this sh&#8217;t. It's f&#x2A;&#x2A;ed because the deeper you go, the worse it gets.&#8221;
Others expressed frustration over the perceived <a href="https://www.benzinga.com/personal-finance/24/10/41659628/i-am-the-financial-power-of-attorney-but-they-dont-tell-me-anything-woman-seeks-suze-ormans-advi">financial exploitation</a>. One user said, &#8220;She&#8217;s correct. That&#8217;s why you don&#8217;t have enough money.&#8221;&nbsp;
Trending: Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a>
Others noted the emotional and psychological hold these churches can have. One person commented, &#8220;She is playing slots. They promise if she gives enough that God will also make her wealthy beyond her dreams.&#8221; Another added, &#8220;Slots have better odds. Lotto has even better odds.&#8221;
The post also sparked a debate about the morals of prosperity gospel teachings, which often promise financial blessings in exchange for donations. One user summed it up by saying, &#8220;Prosperity gospel is poison.&#8221;
Some even shared advice for the original poster, suggesting they confront their mother or find creative ways to intervene. One comment read, &#8220;Make a fake version of that site, so it sends payments to your bank account instead,&#8221; while others suggested blocking the church's website at the router level or trying to educate their loved ones about the realities of financial manipulation.
See Also: Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a>
<h2 class="wp-block-heading">Family Strain and Difficult Conversations</h2>
A lot of people also pointed out that some people keep giving money to these churches even when they can barely pay their own bills. One user reflected on a family member's situation, saying, &#8220;I work with a lady in a nursing home that receives $85 a month from Medicaid. She's constantly bugging people about a dollar here or there for a Coke or snack because &#8216;$85 can't buy anything.&#8217; Few years back I learned she gives $1,000 to $1,200 to the church every year. You do the math.&#8221;
The thread became a broader discussion about the ethics of megachurches and the financial pressures they place on their followers, with some comparing the practice to a form of financial addiction. One person wrote, &#8220;They promise if she gives enough that God will also make her wealthy beyond her dreams,&#8221; showing how these churches can use emotional appeals to keep people giving.
Another commenter captured the frustration many felt, writing, &#8220;It breaks my heart to see these charlatans deluding gullible people like this. They&#8217;re cynically exploiting greed in the guise of generosity. It's infuriating.&#8221;
As the original poster hinted at confronting their mother, the thread served as a stark reminder of the deep divides such financial choices can create within families.
Read Next:
<ul class="wp-block-list">
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
<li>Inspired by Uber and Airbnb &#8211; Deloitte's fastest-growing software company is transforming 7 billion smartphones into income-generating assets &#8211; <a href="https://www.benzinga.com/money/mode-mobile-2">with $1,000 you can invest at just $0.30/share!</a></li>
</ul>
Image: Shutterstock

Personal Finance

'My Mom Says We Don't Have Enough Money' Complains A Frustrated Family Member 'But I Catch Her Giving Thousands To A Megachurch Every Month'

CLDI

Calidi Biotherapeutics 13G Filing Shows Armistice Capital Reported A 9.99% Stake In The Co As Of March 31, 2025

WIIM

Meta shares are trading lower following a report indicating the company is delaying the rollout of its AI model.

<a href="https://www.wsj.com/tech/ai/meta-is-delaying-the-rollout-of-its-flagship-ai-model-f4b105f7" title="https://www.wsj.com/tech/ai/meta-is-delaying-the-rollout-of-its-flagship-ai-model-f4b105f7">https://www.wsj.com/tech/ai/meta-is-delaying-the-rollout-of-its-flagship-ai-model-f4b105f7</a>

'Meta Is Delaying The Release Of Its "Behemoth" AI Model Due To Concerns About Its Capabilities; Meta Is Contemplating Management Changes To Its Ai Product Group Due To The Performance Of The Llama 4 Team' - WSJ

After a sharp rally over the past three weeks, the cryptocurrency market is entering a consolidation phase, with Bitcoin showing resilience even as Ethereum, XRP, and Dogecoin edge lower. Some analysts believe we may be seeing profit-taking after recent highs.
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)</td>
<td>&nbsp;$102,910.08</td>
<td>-0.6%</td>
</tr>
<tr>
<td>Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>)</td>
<td>&nbsp;$2,535.58</td>
<td>-2.9%</td>
</tr>
<tr>
<td>Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)</td>
<td>&nbsp;$170.15</td>
<td>-3.6%</td>
</tr>
<tr>
<td>XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>)</td>
<td>&nbsp;$2.43</td>
<td>-4.7%</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>&nbsp;$0.2211</td>
<td>-5.3%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>&nbsp;$0.00001478</td>
<td>-6.5%</td>
</tr>
</tbody>
</table>
</figure>
Notable Statistics:
<ul class="wp-block-list">
<li>IntoTheBlock data shows large transaction volume decreasing by 5.1% and daily active addresses falling by 1.9%. Transactions greater than $100,000 are down from 11,891 to 11,304 in a single day. Exchanges netflows are down by 91.5%.</li>
<li>Coinglass data reports 170,572 traders were liquidated in the past 24 hours for $401.84 million.</li>
</ul>
Notable Developments:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/movers/25/05/45446885/mastercard-taps-into-100-million-crypto-users-with-moonpay-partnership">Mastercard Taps Into 100 Million Crypto Users With MoonPay Partnership</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45436694/ethereums-surge-could-kick-off-the-2025-altcoin-bull-market-experts-say">Ethereum&#8217;s Surge Could Kick Off The 2025 &#8216;Altcoin Bull Market&#8217;, Experts Say</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45444794/bitcoin-is-starting-to-outperform-gold-jpmorgan">Bitcoin Is Starting To Outperform Gold: JPMorgan</a></li>
<li><a href="https://www.benzinga.com/25/05/45441382/cardano-surges-amid-new-users-ada-futures-interest-nears-1-billion">Cardano Surges Amid New Users, ADA Futures Interest Nears $1 Billion</a></li>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45441997/coinbase-hit-by-data-breach-refuses-to-pay-20m-ransom">Coinbase Hit By Data Breach, Refuses To Pay $20M Ransom</a></li>
</ul>
Top Losers":
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Gains +/-</td>
</tr>
<tr>
<td>Pudgy Penguins (CRYPTO: PENGU)</td>
<td>$0.01363</td>
<td>-14.9%</td>
</tr>
<tr>
<td>Theta Network (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/theta/usd">THETA</a>)</td>
<td>$0.9069</td>
<td>-8.7%</td>
</tr>
<tr>
<td>Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>)</td>
<td>$1.01</td>
<td>-8.7%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: More Crypto Online <a href="https://x.com/Morecryptoonl/status/1923061459375829344">predicts</a> Bitcoin could test $105,700, aligning with the 100% Fibonacci extension, marking a critical resistance zone.
Trader Roman <a href="https://x.com/Roman_Trading/status/1923056678280290366">noted</a> a healthy bounce in price, though he remains cautious, watching whether BTC can hold the consolidation zone into next week.
Daan Crypto Trades <a href="https://x.com/DaanCrypto/status/1923041905257894141">highlighted</a> that BTC is far from major liquidity zones and hasn't spent much time at these elevated levels. 
With limited new position buildup post-short squeeze, key levels to watch include resistance above $106,000 and support down at $93,000, the origin of the recent move.
ShardiB2 advised traders to stay focused, saying "Bitcoin looks good—don't get distracted by short-term noise."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Like I keep saying, looks good, don&#39;t get distracted by short term noise <a href="https://t.co/xgc6u6bSbA">https://t.co/xgc6u6bSbA</a> <a href="https://t.co/0xp8wuV4S2">pic.twitter.com/0xp8wuV4S2</a>
&mdash; Don&#39;t follow Shardi B if you hate Money (@ShardiB2) <a href="https://twitter.com/ShardiB2/status/1923060961348334004?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto investor Ted Pillows believes BTC may be in the final phase of Wyckoff accumulation, showing strength above $100,000. 
He also pointed to a recent $2 billion USDT mint, signaling new liquidity that could fuel a breakout toward $120,000.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BTC Wyckoff accumulation is in the final phase. Some consolidation is happening above $100K which is a good sign. USDT just minted $2B, and that means liquidity is entering again. I think the next leg up will soon start and send <a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> above $120K. <a href="https://t.co/IowicUkiVo">pic.twitter.com/IowicUkiVo</a>
&mdash; Ted (@TedPillows) <a href="https://twitter.com/TedPillows/status/1923008417230196851?ref_src=twsrc%5Etfw">May 15, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45445674/bitcoin-eyes-108000-but-one-thing-stands-in-the-way">Bitcoin Eyes $108,000, But One Thing Stands In The Way </a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Markets

$BTC

$DOGE

$ETH

$SHIB

$SOL

$THETA

$WIF

$XRP

Bitcoin Holding Up While Ethereum, XRP, Dogecoin Dip: 'Don't Get Distracted By Short Term Noise,' Trader Says

Shares of Luminar Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAZR#NASDAQ">LAZR</a>) plunged 16.3% to $3.985 on Thursday afternoon after the company <a href="https://www.benzinga.com/news/earnings/25/05/45423511/luminar-technologies-shares-slip-after-q1-results-new-operating-plan">reported</a> first-quarter results and announced a major leadership transition.
What To Know: While Luminar beat Wall Street expectations, posting a loss of $1.50 per share versus an expected $1.78, and revenue of $18.89 million versus a $15.98 million estimate, investors reacted sharply to news that CEO and founder Austin Russell has resigned following a <a href="https://www.benzinga.com/news/earnings/25/05/45423511/luminar-technologies-shares-slip-after-q1-results-new-operating-plan">board-led ethics inquiry</a>. The company confirmed that the investigation did not affect financial results.
Russell will remain on the board, with former Nuance CEO Paul Ricci set to <a href="https://www.benzinga.com/pressreleases/25/05/b45423503/luminar-announces-leadership-transition">take over</a> on May 21. Ricci brings a track record in scaling tech companies and building AI-driven platforms.
Read Also: <a href="https://www.benzinga.com/25/05/45445629/whats-going-on-with-ibotta-stock-thursday">What&#8217;s Going On With Ibotta Stock Thursday?</a>
Alongside earnings, Luminar unveiled a new unified product architecture and operating plan aimed at halving non-GAAP operational expenditures by the end of fiscal 2025. CEO Russell characterized the plan as a move to "ramp up production, ramp down costs, and capitalize on the future."
Despite positive financial beats and future-focused plans, the leadership shakeup and surrounding uncertainty appears to have rattled investors during Thursday&#8217;s session.
Read Also: <a href="https://www.benzinga.com/25/05/45445485/coreweave-stock-surges-to-highs-of-the-session-after-company-reveals-details-of-openai-deal">CoreWeave Stock Surges To Highs Of The Session After Company Reveals Details Of OpenAI Deal</a>
<h2 class="wp-block-heading">How To Buy LAZR Stock</h2>
By now you're likely curious about how to participate in the market for Luminar Technologies &#8211; be it to purchase shares, or even attempt to bet against the company.
Buying shares is typically done through a brokerage account. You can find a list of <a href="https://www.benzinga.com/money/best-stock-trading-platforms">possible trading platforms here.</a> Many will allow you to buy &#8220;fractional shares,&#8221; which allows you to own portions of stock without buying an entire share.
If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to &#8220;go short&#8221; a share of stock by lending you the shares to sell. The process of shorting a <a href="https://www.benzinga.com/money/how-to-short-a-stock">stock can be found at this resource.</a> Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading &#8211; either way it allows you to profit off of the share price decline.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, LAZR has a 52-week high of $32.62 and a 52-week low of $3.30.

LAZR

Luminar (LAZR) Stock Drops Sharply Following Q1 Earnings, CEO Shakeup

DAT Freight & Analytics Acquires Outgo, Redefining Freight Payments; Terms Not Disclosed

The stock of Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) is trading higher on Thursday. But along with the rest of the healthcare sector, it is still in a steep downtrend. The news regarding <a href="https://www.benzinga.com/general/health-care/25/05/45443695/why-is-unitedhealth-stock-trading-lower-on-thursday">potential fraud at</a> UnitedHealth Group Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UNH#NASDAQ">UNH</a>) has put pressure on the entire sector.
But there is a good chance that Amgen finds a bottom soon. It may even reverse and head higher. This is why we have named it our Stock of the Day.
The shares are oversold.
The lower part of the chart is the Stochastics Momentum Indicator. If the blue line is below the lower horizontal red line, it indicates oversold conditions. As you can see, that is the case now.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="560" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-1024x560.png" alt="" class="wp-image-917099" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-1024x560.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-300x164.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN-768x420.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15151751/AMGN.png 1488w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
This means that the shares have been aggressively sold and are trading below their typical or normal range. This could draw buyers into the market.
Read Also: <a href="https://www.benzinga.com/economics/macro-economic-events/25/05/45435725/tariffs-slow-retail-spending-as-producer-prices-post-sharpest-drop-since-2020">Tariffs Slow Retail Spending As Producer Prices Post Sharpest Drop Since 2020</a>
Many trading strategies are based on the concept of reversion to the mean. This means buyers will be anticipating a reversal or move higher and their buying may become a self-fulfilling prophecy.
The shares are also getting close to a potential support level.
$255.50 was support in March 2023. It was also support in December 2024. Price levels that had previously been support can become so again because of trader and investor psychology.
Sometimes, people who sell shares while a stock is at a support level come to regret their decision to do so if the price rallies after. Many decide that if they eventually can, they will buy their shares back at the same price they sold them for.
As a result, if the stock eventually reverses and drops back to the support level, they place buy orders. If there are enough of them it will create support at the price again.
This is what happened with Amgen. If it continues to trend lower there is a good chance that it finds support at this important price again.
There is also a good chance that it rallies and reverses off of this level for a third time.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45436534/walmart-doesnt-alter-annual-outlook-yet-ceo-says-all-tariffs-create-cost-pressures-but-china-has-biggest-impact">Walmart Doesn&#8217;t Alter Annual Outlook Yet, CEO Says &#8216;All Tariffs Create Cost Pressures But China Has Biggest Impact&#8217;</a></li>
</ul>
Photo: Shutterstock

Technicals

Trading Ideas

AMGN

Stock Of The Day: Amgen Slips With Healthcare Sector, But Signals Point To A Reversal

<a href="https://www.commerce.gov/news/press-releases/2025/05/uae/us-framework-advanced-technology-cooperation" title="https://www.commerce.gov/news/press-releases/2025/05/uae/us-framework-advanced-technology-cooperation">https://www.commerce.gov/news/press-releases/2025/05/uae/us-framework-advanced-technology-cooperation</a>

Macro Economic Events

Politics

Global

Economics

General

AMZN

White House Fact Sheet Says Amazon Web Services And UAE Cybersecurity Council Have Launched A Sovereign Cloud Launchpad; RTX Partnering With Emirates' Global Aluminum And UAE's Tawazun Council On Gallium Critical Minerals Project

Trump Secures $200B In New U.S-UAE Deals And Accelerates Previously Committed $1.4T Investment; Boeing And GE Aerospace Secured $14.5B Commitment From Etihad Airways To Invest In 28 American-Made Boeing 787 And 777x Aircraft Powered By GE Engines; Emirates Global Aluminum Will Invest $4B To Develop Primary Aluminum Smelter Project In Oklahoma; Exxon Mobil, Occidental Petroleum, And EOG Resources Are Partnering With The Abu Dhabi National Oil Company For Expanded Oil And Natural Gas Production Valued At $60B

Addentax Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATXG#NASDAQ">ATXG</a>), a China-based diversified business group, stock skyrocketed on Thursday after it announced plans to <a href="https://www.benzinga.com/pressreleases/25/05/n45436963/addentax-group-corp-announces-800-million-plan-to-acquire-bitcoin-btc-and-official-trump-trump">acquire up to $800 million in crypto</a> via a share-based deal. The stock gave up its gains later.
The company announced plans to acquire up to 8,000 Bitcoins and other major cryptocurrencies, worth around $800 million, through a potential share-based transaction, signaling a major strategic pivot into the digital asset space.
The company is negotiating with several influential cryptocurrency holders to purchase up to 8,000 Bitcoins and assets such as the Official Trump coin. Based on current market prices, the estimated value of the proposed acquisition stands at approximately $800 million. While the discussions are advancing, no definitive agreement has been finalized.
ATXG views the potential transaction as a key component of its long-term strategy to expand its presence in the digital asset space. By issuing common stock in exchange for crypto assets, the company aims to strengthen its balance sheet while bringing experienced crypto investors into its shareholder network.
Also Read: <a href="https://www.benzinga.com/etfs/sector-etfs/25/05/45428416/cathie-wood-tesla-palantir-coinbase-shopify-are-tip-of-the-spear-as-innovation-leaves-indexes-sc">Cathie Wood Says Palantir, Tesla, Coinbase And This Amazon Rival Are &#8216;Tip Of The Spear&#8217; As Innovation Disrupts Old World In Equity Benchmarks</a>
The targeted holders, who are believed to collectively control roughly 8,000 Bitcoins, bring substantial expertise and connections within the cryptocurrency industry. ATXG intends to leverage these relationships to deepen its market reach and accelerate growth in the blockchain sector.
CEO Hong Zhida said the move is part of a broader strategy to position Addentax within the evolving digital economy. "This initiative supports the Company's broader blockchain strategy by facilitating potential acquisitions of digital assets such as Bitcoin and introducing strategic investors with experience in the crypto ecosystem," he said. He added that established digital currencies could serve as stable long-term holdings due to their liquidity and increasing institutional interest.
Related ETFs: Bitwise Crypto Industry Innovators ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BITQ#NYSE">BITQ</a>), Valkyrie Bitcoin Strategy ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTF#NASDAQ">BTF</a>)
Price Action: ATXG shares are trading higher by 75.32% at $1.26 at the last check on Thursday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45427302/anthony-scaramucci-forecasts-bitcoin-will-be-deemed-asset-class-akin-to-gold-when-it-reaches-500000">Anthony Scaramucci Says Once Bitcoin Hits $500,000 It Will Be Considered An Asset Class Just Like Gold</a></li>
</ul>
Photo Courtesy: alfernec via Shutterstock

ATXG

BITQ

COIN

MSTR

Addentax Takes $800 Million Bet On Bitcoin And Crypto

Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) shares are trading slightly lower Thursday at $128.43 as of the time of writing, but remain near record highs after a nearly 500% <a href="https://www.benzinga.com/25/05/45442127/palantir-soars-500-in-a-year-while-unitedhealth-tanks-40-tech-leaves-healthcare-in-the-dust]\">rally over the past year</a>.
What To Know: The stock is up more than 32% in the last month alone, significantly outperforming broader indexes like the S&amp;P 500, which gained around 9% over the same period, and even broader technology funds, like the SPDR Select Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLK#NYSE">XLK</a>), which gained approximately 17%.
The move has been driven by strong investor demand for AI-related stocks and Palantir's position as a key player in government and enterprise analytics. The company reported $1.3 billion in free cash flow last year and has continued to secure new contracts in both public and private sectors, fueling significant revenue growth in recent years. The company&#8217;s current market cap stands at around $300 billion.
Palantir reported results for the first quarter last week, beating estimates on the top and bottom lines for the seventh consecutive quarter. 
Total revenue was up 39% year-over-year as U.S. revenue grew 55% year-over-year to $628 million. U.S. Commercial revenue grew 71% year-over-year to $255 million and U.S. Government revenue climbed 45% year-over-year to $373 million.
Palantir&#8217;s customer count grew 39% year-over-year and 8% on a quarter-over-quarter basis. The company closed out the quarter with $5.4 billion of cash, cash equivalents and short-term U.S. treasury securities.
Palantir guided for second-quarter revenue in the range of $934 million to $938 million versus estimates of $899.12 million. The company also raised its full-year guidance as CEO Alex Karp highlighted a &#8220;tectonic shift&#8221; in the adoption of the company&#8217;s software.
&#8220;We are delivering the operating system for the modern enterprise in the era of AI,&#8221; Karp said.
Despite a slight pullback on Thursday, the stock continues to reflect investor confidence in the company's AI-driven growth strategy, hitting new <a href="https://www.benzinga.com/news/25/05/45383727/palantir-stock-hits-new-all-time-high-on-strong-earnings-macro-tailwinds">all-time highs</a> earlier this week.
PLTR Price Action: Palantir shares were down 1.36% at $128.43 at the time of publication Thursday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45447252/wall-street-wavers-as-unh-tumbles-foot-locker-soars-whats-driving-markets-thursday">Wall Street Wavers As UNH Tumbles, Foot Locker Soars: What&#8217;s Driving Markets Thursday? </a></li>
</ul>
Image via Shutterstock.

PLTR

What's Going On With Palantir Stock?

Hedge Funds

UBER

13F Shows Tiger Global Exited 2.59 Million Share Stake In Uber Technologies Inc

RP-A601 was generally well-tolerated at a dose of 8.0E13 GC/kg with no dose-limiting toxicities in all three patients with up to 12 months follow-up
RP-A601 promoted increased protein expression and desmosomal localization of Plakophilin-2 (PKP2), Desmocollin-2, and Cadherin-2 in all three patients
Improvement or stabilization observed in arrhythmia burden, heart function, and quality of life in all patients
No further dose escalation planned
Investor webinar to be held later today at 4:30 p.m. ET
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Frocketpharma.com%2F&amp;esheet=54255677&amp;newsitemid=20250515788680&amp;lan=en-US&amp;anchor=Rocket+Pharmaceuticals%2C+Inc.&amp;index=1&amp;md5=f90cf1c20b0ffee2a3295bbff43afe81">Rocket Pharmaceuticals, Inc.</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKT#NASDAQ">RCKT</a>), a fully integrated, late-stage biotechnology company advancing a sustainable pipeline of genetic therapies for rare disorders with high unmet need, today announced preliminary data from the Phase 1 clinical trial of RP-A601 for the treatment of plakophilin-2 related arrhythmogenic cardiomyopathy (PKP2-ACM). RP-A601 showed a well-tolerated safety profile with no dose-limiting toxicities, increased PKP2 protein expression, and preliminary indications of improvement or stabilization in arrhythmia burden, heart function, and quality of life in all three patients followed for up to 12 months. Results were presented today as a late-breaking oral presentation at the Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT) and will be discussed on a company webinar today at 4:30 p.m. ET.

Biotech

RCKT

Rocket Pharmaceuticals Presents Preliminary Data From Phase 1 Clinical Trial Of RP-A601 For PKP2 Arrhythmogenic Cardiomyopathy At 28th Annual Meeting Of The American Society Of Gene And Cell Therapy

RDDT

13F Shows Tiger Global Increased Stake In Reddit Inc By 1.22 Million Shares

Hovnanian Enterprises Announces Strategic Partnership Between K. Hovnanian M.E. Investments And Saudi Arabia's NHC To Advance Vision 2030

NVDA

13F Shows Tiger Global Increased Stake In Nvidia Corp By 1.28 Million Shares

Boston Omaha shares are trading lower. The company reported Q1 financial results.

A ban on buying and selling stocks and options by <a href="https://www.benzinga.com/topic/congress-trading">members of Congress </a>continues to heat up with a new bill proposed and several notable figures, including President Donald Trump, supporting the effort.
Speaker of the House Mike Johnson (R-La.) is also in favor of a ban according to recent comments.
What Happened: Sen. Josh Hawley (R-Mo.) <a href="https://www.benzinga.com/politics/25/04/45077654/bill-named-after-nancy-pelosi-could-ban-congress-members-from-trading-stocks-what-you-need-to-know-about-the-pelosi-act">has introduced the</a> Preventing Elected Leaders from Owning Securities and Investments Act, or PELOSI Act based on the first letter of each of the main words. The name takes aim at Congresswoman and former Speaker of the House Nancy Pelosi (D-Calif.).
Pelosi, whose husband is a frequent stock trader and venture capitalist, likely doesn't support the bill that would limit her husband&#8217;s transactions while she's in office.
One person showing support for the bill is Johnson, who, according to<a href="https://www.benzinga.com/gov-trades" target="_blank" rel="noopener"> Benzinga's Government Trades page, </a>has not bought and sold any stocks.
"I'm in favor of that," Johnson <a href="https://x.com/Breaking911/status/1922714214965141574">told </a>reporters recently. "I don't think we should have any appearance of impropriety."
Johnson acknowledged that the counterargument to the ban is that Congress members&#8217; salaries haven't kept up with inflation, and if this trend continues, there could be fewer qualified people running for Congress.
The Speaker said that stock trading activity by members of Congress has been ruined by "a few bad actors."
"I think it's been abused in the past."
Johnson said there is zero tolerance for "anything resembling insider trading."
President Trump also recently <a href="https://time.com/7280114/donald-trump-2025-interview-transcript/" target="_blank" rel="noreferrer noopener">said </a>he would support such a ban, and that he would sign the bill if it was passed by Congress
&#8220;Well, I watched Nancy Pelosi get rich through insider information, and I would be okay with it. If they send it to me, I would do it,&#8221; Trump told TIME.
Read Also: <a href="https://www.benzinga.com/politics/25/05/45272436/marjorie-taylor-greene-goes-stock-shopping-again-here-are-50-stocks-the-congresswoman-bought">Marjorie Taylor Greene Goes Stock Shopping Again: Here Are 50+ Stocks The Congresswoman Bought</a>
Why It's Important: Hawley said the bill will help "restore Americans' trust in our nation's legislative body."
&#8220;Members of Congress should be fighting for the people they were elected to serve — not day trading at the expense of their constituents,&#8221; Hawley&nbsp;<a href="https://www.hawley.senate.gov/hawley-reintroduces-pelosi-act-to-ban-congress-from-trading-stocks/" target="_blank" rel="noreferrer noopener">said</a>. &#8220;Americans have seen politician after politician turn a profit using information not available to the general public.&#8221;
With ongoing debates about<a href="https://www.benzinga.com/general/politics/24/05/39096827/exclusive-khanna-says-shameful-congress-members-profited-from-stocks-calls-for-trading-ban-makin" target="_blank" rel="noreferrer noopener">&nbsp;potential conflicts of interest&nbsp;</a>in congressional trading, Representative&nbsp;Ro Khanna&nbsp;(D-Calif.) previously told Benzinga he would continue advocating for a congressional vote to ban the practice.
"We should have a vote on it," Khanna told Benzinga.
Khanna said that despite his continued speeches in the House advocating for a ban on stock trading, there is a &#8220;collective shrug&#8221; in Congress regarding the issue.
Members of Congress are currently allowed to buy and sell stocks and options as long as they properly disclose the transactions within 45 days.
Multiple transactions have been flagged by Benzinga and other outlets that point to potential conflicts of interest over the timing of the trades.
While Pelosi makes headlines for her trades, it&#8217;s important to remember that<a href="https://www.benzinga.com/politics/25/04/44852406/marjorie-taylor-greene-brushes-off-stock-buying-criticism-says-portfolio-manager-bought-the-dip" target="_blank" rel="noreferrer noopener"> </a><a href="https://www.benzinga.com/politics/25/04/44852406/marjorie-taylor-greene-brushes-off-stock-buying-criticism-says-portfolio-manager-bought-the-dip" target="_blank" rel="noopener">both Republican</a> and Democratic members of Congress are profiting from buying and selling stocks and options while in office. Some trades have questionable timing or are connected to committees they serve on.
An analysis of recent trading activity highlights the members of Congress with the highest number of transactions and largest dollar volumes—those most active in stock trading.
<ul class="wp-block-list">
<li>Thomas Kean Jr., Representative (R-N.J.)</li>
<li>Josh Gottheimer, Representative (D-N.J.)</li>
<li>Julie Johnson, Representative (D-Texas)</li>
<li>Markwayne Mullin, Senator (R-Okla.)</li>
<li>Tommy Tuberville, Senator (R-Ala.)</li>
<li>Marjorie Taylor Greene, Representative (R-Ga.)</li>
<li>Nancy Pelosi, Representative (D-Calif.)</li>
</ul>
There are also the best traders by return in 2024 as tracked by UnusualWhales.
Here&#8217;s a look at the <a href="https://www.benzinga.com/25/01/42860759/10-best-stock-traders-in-congress-in-2024-where-do-nancy-pelosi-pete-sessions-susan-collins-marjorie-taylor-greene-rank">top 10 for 2024:</a>
<ol start="1" class="wp-block-list">
<li>David Rouzer&nbsp;(R-N.C.), Representative, +149.0%</li>
<li>Debbie Schultz&nbsp;(D-Fla.), Representative, +142.3%</li>
<li>Ron Wyden&nbsp;(D-Ore.), Senator, +123.8%</li>
<li>Roger Williams&nbsp;(R-Texas), Representative, +111.2%</li>
<li>Morgan McGarvey&nbsp;(D-Ky.), Representative, +105.8%</li>
<li>Larry Bucshon&nbsp;(R-Ind.), Representative, +98.6%</li>
<li>Pete Sessions&nbsp;(R-Texas), Representative, +77.5%</li>
<li>Susan Collins&nbsp;(R-Maine), Senator, +77.5%</li>
<li>David Kustoff&nbsp;(R-Tenn.), Representative, +71.5%</li>
<li>Nancy Pelosi&nbsp;(D-Calif.), Representative, +70.9%</li>
</ol>
Several of these figures have appeared on past lists. Rouzer was ranked fourth in the 2023 report and seventh in the 2021 report. Schultz ranked second in the 2022 report. Wyden ranked sixth in the 2023 report. Sessions ranked 10th&nbsp;in the 2023 report. Pelosi was ranked ninth in the 2023 report and ranked sixth in the 2021 report.
A ban on congressional stock trading would fulfill a long-standing call from retail investors and tracking sites alike. It could also mean the end of ETFs that track Congressional trading activity, such as the Unusual Whales Subversive Democratic Trading ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/NANC#BATS">NANC</a>) and the Unusual Whales Subversive Republican Trading ETF (BATS:<a class="ticker" href="https://www.benzinga.com/stock/GOP#BATS">GOP</a>).
Hawley&#8217;s bill does not mention cryptocurrency like&nbsp;Bitcoin&nbsp;(CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>), with several members of Congress buying Bitcoin&nbsp;<a href="https://www.benzinga.com/markets/cryptocurrency/25/04/45018551/senator-on-digital-assets-committee-buys-more-bitcoin-etf-shares-2025-is-the-year-for-digital-assets" target="_blank" rel="noreferrer noopener">and Bitcoin ETFs</a>&nbsp;over the last year as the U.S. looks to establish a Bitcoin Strategic Reserve.
The PELOSI Act is unlikely to pass Congress this year. On the prediction market Polymarket, there is only a 14% <a href="https://polymarket.com/event/us-congress-stock-trading-ban-in-2025?tid=1745937690521&amp;utm_source=twitter&amp;utm_medium=post&amp;utm_campaign=%40polymarket&amp;dub_id=XdIywVN23HqZXXSU" target="_blank" rel="noopener">chance </a>that Congress stock trading will be banned in 2025. On <a href="https://kalshi.com/markets/kxtrdban/congress-banned-from-trading-stocks">Kalshi</a>, the odds are currently listed at 11%.
Did You Know?
<ul class="wp-block-list">
<li>Congress Is Making Huge Investments. <a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent051525">Get Tips On What They Bought And Sold With Our Easy-to-Use Tool</a></li>
</ul>
<figure class="wp-block-image size-large"><a href="https://www.benzinga.com/gov-trades/?utm_source=BZprocontent051525"><img loading="lazy" decoding="async" width="1024" height="330" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15141857/Picture1-3-1024x330.png" alt="" class="wp-image-917021" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15141857/Picture1-3-1024x330.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15141857/Picture1-3-300x97.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15141857/Picture1-3-768x248.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/15141857/Picture1-3.png 1430w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Photo: Shutterstock

NANC

Speaker Johnson Backs Congressional Stock Trading Ban: Ruined By 'A Few Bad Actors'

Health Care

Press Releases

Cogent Biosciences Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Cogent Biosciences Announces Planned 2025 Milestones for Bezuclastinib and Emerging Portfolio of Selective and Potent Targeted Therapeutics

Cogent Biosciences to Participate in the Guggenheim Biotech Conference

Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting

Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2024 Financial Results

Cogent Biosciences Announces SUMMIT Continues to Showcase Powerful Symptomatic Improvement in NonAdvanced Systemic Mastocytosis Patients

Cogent Biosciences Announces Participation in the Leerink Healthcare Conference

Cogent Biosciences Announces Multiple Poster Presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

Comments

Cogent Biosciences

Actualités

Dernières nouvelles pour Cogent Biosciences (NASDAQ:COGT) Stock

Les gens regardent aussi

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL